Provider
QP79-20 Introducing the Blue Cross Blue Shield System’s New National High-Performance Network
Program effective Date: Aug 26, 2020
Documents & Forms Results
Displaying 2271 - 2280 of 3111 results
Provider
QP64R1-20 Medical Drug Update for New to Market Viltolarsen (Viltepso)
Program effective Date: Aug 26, 2020
Provider
QP80-20 MHCP Pharmacy Benefit Update - AvsolaTM, Ilaris® and PerserisTM
Program effective Date: Aug 26, 2020
Provider
QP78-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa®
Program effective Date: Aug 26, 2020
Provider
QP77-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid
Program effective Date: Aug 26, 2020
Provider
QP82-20 Commercial Pharmacy Benefit Exclusion for Amzeeq™ (minocycline) foam, brimonidine ophthalmic solution 0.15% and ProAir® (albuterol sulfate) HFA
Program effective Date: Aug 26, 2020
Provider
2020 September Provider Press
Program effective Date: Aug 19, 2020
Provider
QP76-20 Outlier Outpatient Therapy Management Program
Program effective Date: Aug 12, 2020
Provider
QP74-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa PA with QL
Program effective Date: Aug 12, 2020
Provider
QP73-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid PA with QL
Program effective Date: Aug 12, 2020